BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALSnews2023-10-18T10:55:54+00:00October 18th, 2023|Medical Device News Magazine|
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapiesnews2023-10-13T18:59:30+00:00October 13th, 2023|Medical Device News Magazine|
Readygo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samplesnews2023-10-10T10:05:13+00:00October 10th, 2023|Medical Device News Magazine|
Newly Published Data Supports Effectiveness of BIOTRONIK Neuro’s RESONANCE ™ Stimulationnews2023-10-05T13:15:59+00:00October 5th, 2023|Medical Device News Magazine|
Ariceum Therapeutics’ Targeted Radiopharmaceutical 177Lu-satoreotide Exhibits Promising Clinical Response and Good Tolerability Profile in Patients with Advanced Neuroendocrine Tumoursnews2023-09-28T11:39:29+00:00September 28th, 2023|Medical Device News Magazine|
New Hot Start Isothermal Mixes Boost Sensitivity, Specificity, and Speed of DNA Target Detectionnews2023-09-27T13:49:03+00:00September 27th, 2023|Medical Device News Magazine|
Branded Legacy Invests Heavily in Innovation and Growth with $540,000 Expansionnews2023-09-26T16:42:45+00:00September 26th, 2023|Medical Device News Magazine|
Cue Biopharma Completes Patient Enrollment in Ph1b Head & Neck Cancer Trialnews2023-09-26T15:41:15+00:00September 26th, 2023|Medical Device News Magazine|
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Curenews2023-09-26T11:41:34+00:00September 26th, 2023|Medical Device News Magazine|
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trialnews2023-09-22T11:02:16+00:00September 22nd, 2023|Medical Device News Magazine|
